Healthcare News and Research

Latest Healthcare News and Research

Hong Kong health commitment pledged in Sweden

The SARS crisis was a reminder of the need for a strong commitment to enhancing public health infrastructure and global co-operation against communicable diseases.

28 Sep 2004

Half of sildenafil samples purchased on the internet were fake

Around half of the Viagra samples purchased on the Internet were counterfeit, according to researchers who are today announcing a new technique that detects counterfeit medicines at the British Pharmaceutical Conference.

27 Sep 2004

Findings have implications for understanding psychiatric and neurological disease that affect the hippocampus

Spatial memory is more vulnerable than object recognition memory when damage occurs in the brain’s memory processing center, the hippocampus, according to memory specialists at the University of California, San Diego (UCSD) School of Medicine

27 Sep 2004

Study of mental health of assisted living residents has found a higher rates of mental health problems than expected

The first large scale comparative study of the mental health of assisted living residents has found a higher rate than expected of a range of mental health problems in this rapidly growing population.

27 Sep 2004

Prop. 71 will generate a total of at least $6.4 to $12.6 billion in new state revenues

The San Diego Regional Chamber of Commerce and the Contra Costa Council, two of the State's leading regional business advocacy organizations, today announced their endorsements of Proposition 71, the California Stem Cell Research and Cures Initiative.

26 Sep 2004

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004

Palladone approved for pain relief

The Food and Drug Administration (FDA) has approved Palladone (hydromorphone hydrochloride) capsules for the management of persistent moderate to severe pain in patients requiring continuous around-the-clock opioid pain relief for an extended period of time.

26 Sep 2004

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

AstraZeneca has announced important new data at the 4th European Stanley Foundation Conference on Bipolar Disorder, which show Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder and is also well-tolerated in this difficult to treat patient population.

26 Sep 2004

$16 million investment in minute wireless implant technology

Remon Medical Technologies a privately held medical device company, today announced that it has raised $16 million in the initial close of a Series C financing.

23 Sep 2004

Medicare drug card savings growing, new data show

Seniors are now saving more money with the new Medicare-approved drug discount cards, the nation’s top Medicare official announced today at a forum held by the U.S. Senate Special Committee on Aging.

23 Sep 2004

Patients as well as doctors need to learn to become better communicators with each other

The failure to communicate effectively during medical visits can cause far worse damage than a mild case of frustration, studies show.

23 Sep 2004

Glaxo drops appeal in AIDS drug pricing case

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed after GSK dropped its public and repeated vows to appeal a decision allowing the case to go forward.

22 Sep 2004

GlaxoSmithKline has granted a voluntary licence to Cosmos Limited for the manufacture and sale of antiretrovirals

GlaxoSmithKline currently sells zidovudine (sold as Retrovir®), lamivudine (sold as Epivir®) and the combination of the two molecules (sold as Combivir®) across the region.

22 Sep 2004

Steps to minimise the risk of onward transmission of vCJD

Selected groups of patients are this week being notified about the results of a risk assessment exercise for blood plasma products.

22 Sep 2004

Study into asbestos-related disease shows need for community involvement

Conducted by researchers from the Centre for the Study of Health and Society at the University of Melbourne, the study was spurred by observation that the voices and perspectives of those most affected by asbestos disease are rarely heard in the formulation of responses to Australia’s on-going asbestos disease epidemic.

22 Sep 2004

World's most powerful magnetic resonance imaging machine for human studies

The University of Illinois at Chicago unveiled today the world's most powerful magnetic resonance imaging machine for human studies, capable of imaging not just the anatomy but metabolism within the brain.

21 Sep 2004

Important that nurses help women find ways to bond with their infants when breast-feeding is not possible

New mothers with fibromyalgia (FM) face multiple barriers to breast-feeding their babies, according to a study published recently in the American Journal of Maternal/Child Nursing.

20 Sep 2004

Central to this year's World Alzheimer's Day campaign is the active participation of people with dementia

From Australia to Alaska, thousands of people will gather in countries around the world on Tuesday 21 September to mark World Alzheimer's Day and urge their governments to make dementia a higher healthcare priority.

20 Sep 2004

New computer program helps health departments halt outbreaks

Imagine that a terrorist has just released the smallpox virus in Atlanta, and suddenly there’s a race against time to vaccinate and treat every last man, woman and child in metro Atlanta before the deadly virus can spread.

20 Sep 2004

Investigation into the potential for designing drug treatments based on a person’s genetic makeup

Most current drugs are not effective for 100 per cent of the population and some work in as few as 30 to 50 per cent of cases. Pharmacogenetics, the study of how genetic factors influence a person’s response to a drug, is seen as a way of making treatments as safe and effective as possible for every individual.

20 Sep 2004

Healthcare News and Research

Latest Healthcare News and Research

Hong Kong health commitment pledged in Sweden

Half of sildenafil samples purchased on the internet were fake

Findings have implications for understanding psychiatric and neurological disease that affect the hippocampus

Study of mental health of assisted living residents has found a higher rates of mental health problems than expected

Prop. 71 will generate a total of at least $6.4 to $12.6 billion in new state revenues

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Palladone approved for pain relief

Seroquel is significantly more effective than placebo in treating patients with rapid-cycling bipolar disorder

$16 million investment in minute wireless implant technology

Medicare drug card savings growing, new data show

Patients as well as doctors need to learn to become better communicators with each other

Glaxo drops appeal in AIDS drug pricing case

GlaxoSmithKline has granted a voluntary licence to Cosmos Limited for the manufacture and sale of antiretrovirals

Steps to minimise the risk of onward transmission of vCJD

Study into asbestos-related disease shows need for community involvement

World's most powerful magnetic resonance imaging machine for human studies

Important that nurses help women find ways to bond with their infants when breast-feeding is not possible

Central to this year's World Alzheimer's Day campaign is the active participation of people with dementia

New computer program helps health departments halt outbreaks

Investigation into the potential for designing drug treatments based on a person’s genetic makeup

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Healthcare News and Research

Latest Healthcare News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in